Saturday, August 02, 2014 12:08:54 AM
So, GTLL is not revoked as many claimed, also there is no proof that they are in marijuana business …as far as I know.
As of Jul 31, 2014 Market Value is $310,503.00 (info from OTC Market website)
No info from the company since 2011 means they are automatically downgraded to OTC Pink No Information. This tier indicates companies that are unwilling or unable to provide disclosure to the public markets. Companies in this category do not make current information available via OTC Markets disclosure and news service, or if they do, the available information is older than six months.
Many people are confusing OTC Pink No Information with Caveat Emptor. Caveat Emptor is the first rule of buying any stock - Buyer Beware!!!
Caveat Emptor - There is a public interest concern associated with the company. This may include a spam campaign, stock promotion or known investigation of fraudulent activity committed by the company or insiders. During a spam campaign, any stock that is not in the Current Information category will also have its quotes blocked on otcmarkets.com
GTLL is on OTC Pink No Information (Not Caveat Emptor) and when they start update their info to SEC again they will be upgraded to higher tier automatically. With all those no bid “sleepers” there is a high probability that suddenly, without any reason, they run high and trade as usual.
I have my free lotto ticket, not planning to quit trading stocks any time soon, so I will stick around and see how it will ends. GL
"Turn those machines back on!"
Recent GTLL News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 01:45:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/06/2024 10:09:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 02:49:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2024 03:56:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:30:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:45:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 02:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:45:16 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:06:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 08:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 01:17:05 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/24/2023 08:39:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 08:27:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM